— Know what they know.
Not Investment Advice
Also trades as: VLA.PA (PAR) · $vol 2M · 0OB3.L (LSE) · $vol 0M · INRLF (OTC) · $vol 0M · VLAP.PA (PAR)

VALN NASDAQ

Valneva SE
1W: -6.5% 1M: -19.4% 3M: +6.3% YTD: -35.9% 1Y: -50.4% 3Y: -50.6% 5Y: -81.7%
$5.74
-0.16 (-2.71%)
 
Weekly Expected Move ±5.1%
$5 $5 $6 $6 $6
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 28 · $544.3M mcap · 90M float · 0.069% daily turnover · Short 32% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$175M +3.0% ▲
5Y CAGR: +9.6%
Gross Profit
$68M -5.0% ▼
5Y CAGR: +3.8%
Operating Income
-$82M -712.4% ▼
Net Income
-$115M -840.6% ▼
EPS (Diluted)
$-1.32 -656.9% ▼
EBITDA
-$50M -257.3% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$348M$361M$154M$170M$175M
YoY Growth+215.5%+3.8%-57.5%+10.3%+3.0%
Cost of Revenue$188M$324M$101M$99M$107M
Gross Profit$160M$37M$53M$71M$68M
Gross Margin46.0%10.2%34.4%41.9%38.7%
R&D Expenses$173M$105M$60M$74M$85M
SG&A Expenses$71M$58M$97M$95M$75M
Operating Expenses$222M$150M$135M$58M$149M
Operating Income-$61M-$113M-$82M$13M-$82M
Operating Margin-17.6%-31.4%-53.4%7.9%-46.7%
Interest Expense$17M$19M$23M$24M$42M
Income Before Tax-$70M-$145M-$99M-$11M-$114M
Tax Expense$3M-$2M$3M$761K$1M
Net Income-$73M-$143M-$101M-$12M-$115M
Net Margin-21.1%-39.7%-66.0%-7.2%-66.0%
EPS (Diluted)$-1.50$-2.48$-1.46$-0.17$-1.32
EBITDA-$39M-$105M-$58M$32M-$50M
Shares Outstanding49M58M69M70M84M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms